Rayonier Reports Third Quarter 2017 Results

• Net income attributable to Rayonier of $24.7 million ($0.19 per share) on revenues of $177.9 million
• Operating income of $39.3 million and Adjusted EBITDA of $69.9 million
• Year-to-date cash provided by operations of $186.9 million and cash available for distribution (CAD) of $143.7 million

Rayonier Inc. (NYSE:RYN) today reported third quarter net income attributable to Rayonier of $24.7 million, or $0.19 per share, on revenues of $177.9 million. This compares to net income attributable to Rayonier of $39.4 million, or $0.32 per share, on revenues of $171.4 million in the prior year quarter. The prior year third quarter results included $1.2 million of costs related to shareholder litigation.1 Excluding this item, pro forma net income2 was $40.6 million, or $0.33 per share, in the prior year period.

Third quarter operating income was $39.3 million versus $49.7 million in the prior year period. Prior year third quarter operating income included $1.2 million of costs related to shareholder litigation.1 Excluding this item, pro forma operating income2 was $50.9 million in the prior year period. Third quarter Adjusted EBITDA2 was $69.9 million versus $87.2 million in the prior year period. The decline in Adjusted EBITDA2 relative to the prior year period was primarily due to lower real estate results, as the prior year period included a $48.3 million sale comprised of 17,772 acres in Georgia.

Year-to-date cash provided by operating activities was $186.9 million versus $163.9 million in the prior year period. Year-to-date cash available for distribution (CAD)2 of $143.7 million increased $20.2 million versus the prior year period primarily due to higher Adjusted EBITDA2 ($25.6 million) and lower cash interest paid ($0.1 million), partially offset by higher capital expenditures ($5.5 million).

“We are pleased with our third quarter results, as all three of our timber segments realized meaningful increases in Adjusted EBITDA relative to the prior year quarter,” said David Nunes, President and CEO. “Southern Timber results reflect 24% higher harvest volumes offset by a modest 1% decrease in average stumpage prices relative to the prior year quarter. Pacific Northwest Timber results improved based on 5% higher harvest volumes and a 17% increase in delivered sawtimber prices relative to the prior year quarter, largely due to strengthening domestic and export markets. New Zealand Timber Adjusted EBITDA more than doubled versus the prior year quarter, driven by 40% higher harvest volumes and increases in export and domestic sawtimber prices of 16% and 11%, respectively. In Real Estate, lower results this quarter compared to the prior year quarter were driven by a large decrease in the number of acres sold, partially offset by significantly higher average pricing, which reflects a 1,300-acre unimproved development sale for $10,000 per acre.”
more detail at:  http://phx.corporate-ir.net/phoenix.zhtml?c=91500&p=irol-irhome

Related Posts

Billerud Interim report January–June 2023

The second quarter was challenging with all-time low sales volumes and with currency-neutral net sales declining by 18% compared to the same period last year. The largest sales decline was in North America due to the continued inventory destocking resulting in production curtailments. This, in combination with historically high fiber costs in Europe led to a weak result. By all indications, the blastomycosis outbreak at the Escanaba mill is behind us. Following a three-week idling and deep cleaning of the facilities, operations were successfully resumed on the 8th of May. We continue to work closely with local, state and federal health experts as they complete their analysis of the testing and sample collection at the mill. Results will be made publicly available in due course. The negative financial impact of the outage and the deep clean was SEK 85 million in the quarter. From the 1st of April, our financial results are reported according to a regional structure. Business conditions differ vastly between Europe and North America, even if the current situation of high inventories and destocking applies to both regions. Region Europe’s profitability deterioration in the second quarter was primarily due to all-time-high fiber cost and soft volumes. Region North America on the other hand delivered a comparatively healthy margin, despite an operating rate of 50-60%, thanks to our cost-leadership and tight cost control.

Toscotec’s tissue line exceeds production target at EuroVast Group

Italian tissue manufacturer EuroVast fired up a new Modulo-Plus tissue machine supplied by Toscotec at its Cartiera della Basilica paper mill in Villa Basilica, Lucca, Italy. PM5 is running efficiently at the speed of 1,600 m/min and since its start-up in February, it has exceeded the project’s production targets with excellent results in energy consumption. The new line completely replaced the mill’s existing PM5, a suction breast roll machine. The sheet width is 2,770 mm and the production capacity is over 30,000 tpy. It is equipped with a single press TT BlindDrilledPressRoll, a TT SYD and gas-fired TT Hoods. PM5 produces toilet tissue, kitchen towels and napkins from 100% pre-dried virgin pulp. EuroVast also purchased a complete service package including dismantling operations, erection, training, commissioning, and start-up assistance.

Mondi Gronau starts production of more than one million medical face masks per day in Germany

Mondi has started up new production lines for melt-blown nonwoven fabric and medical face masks at its site in Gronau, Germany to mitigate the spread of COVID-19. Mondi Gronau has over 50 years of experience in the production and processing of films, nonwovens and elastic components for hygiene products. Last year Mondi announced it would start up production lines to produce both the important base material, melt-blown nonwoven fabric, as well as the medical face mask themselves. With the new lines, Mondi is building up a local value chain in Germany to address the needs of the pandemic. The fully integrated production with two highly automated high-speed machines allows the output of 700 high-quality medical face masks per minute. This is approximately seven times higher than the standard face mask production line and will produce at least one million medical grade masks a day. The masks are certified as a medical product by the German Johner Institute as well as meeting the German standards OEKO-TEX and Dermatest.
Back To Top
×Close search
Search